Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Poland stocks higher at close of trade; WIG30 up 1.11%

Poland stocks higher at close of trade; WIG30 up 1.11%

Polish stocks experienced a surge after the market closed on Friday, with the Warsaw Stock Exchange's WIG30 index rising 1.11% to set a new all-time high. The Media, Construction, and Information Technology sectors saw the biggest gains, propelling shares higher throughout the session. X Trade Brokers Dom Maklerski SA led the pack, soaring 5.51% or 7.72 points to close at 147.82.

Cyfrowy Polsat SA and Pepco Group NV also outperformed, climbing 5.38% and 5.10% respectively, reaching all-time highs at 18.30 and 48.00. On the flip side, PGE Polska Grupa Energetyczna SA suffered the steepest drop, losing 4.43% or 0.77 points to close at 16.50. Tauron Polska Energia SA and Enea SA followed suit, slipping 4.00% and 1.80% respectively.

The number of rising stocks surpassed declining ones, with 315 outperforming 227, and 101 ending unchanged. Shares in Cyfrowy Polsat and Pepco Group reached their 52-week and 3-year highs, respectively. Crude oil prices for November delivery dipped slightly, while Brent oil for December delivery and gold futures both saw modest gains. Currency pairs EUR/PLN and USD/PLN remained stable, while the US Dollar Index Futures declined.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at investing.com →

More in Finance & Markets

Will Broadcom Rejoin the $2 Trillion Club in 2027?

Broadcom supplies some of the best data center chips and components for developing artificial intelligence.

  • Broadcom previously part of $2 trillion club, now 26% off June high
  • AI labs propose scaling back development, Broadcom s GPUs replaced by Nvidia, AMD
  • Broadcom forecasts $115B AI revenue in 2027, $230B in 2028 to rejoin club

Novo Nordisk and Eli Lilly Just Got Some Fantastic News

A new government-funded study found that GLP-1 drugs slow the aging process in mice.

  • Semaglutide extended lifespan of older mice by counteracting aging effects.
  • Mice treated with semaglutide showed improved muscle and cognitive function.
  • GLP-1 drug market use nearly quadrupled in Americans since 2024.

More from Friday 16 October →